Wuhan Back In Spotlight As Delta Variant Highlights Booster Shots Urgency
Delta Variant Poses New Challenges To China
Executive Summary
Amid surging infections in several cities including Wuhan, China is urging vaccination among unvaccinated people, but a booster shot may be needed soon to address a low efficacy among Chinese vaccines, some say.
You may also be interested in...
Antibody COVID-19 Therapies Back in China Spotlight Amid Infection Surge
Chinese developers forge ahead with research into antibody therapies for COVID-19 as coronavirus variants gain a toe-hold in the country.
China VBP, Localization And Other Strategies - How Far And Which Way?
Could health sector players encounter issues similar to those facing Tesla in China, a country which virtually saved the electric vehicle maker but where it is now facing challenges? Are there any lessons to be learned from a success story under China's volume-based procurement scheme? A partner at EY looks at these and other issues.
Medtechs Must Reflect On China Localization Policies As VBP Expands
China continues to roll out volume-based procurement for medical devices and pharma products and companies should plan their strategies accordingly, advises EY Parthenon’s Hua Su.